Skip to main content

Table 5 Baseline information and in-hospital mortality

From: Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study

Patients Characteristics O+P group O group P value
all patients included in the study n = 82 n = 39 n = 43  
  Age (years): mean (SD) 56.51(13.86) 59.74(14.71) 0.53
  No. of male (%) 27(69.23 %) 29(67.44 %) 1.0
  Time from symptom onset to NAIs administration (days):median(IQR) 7.00(5.00,8.00) 5.00(4.00,7.00) 0.16
  APACHE II score: mean(SD) 19.05(8.41) 21.09(8.33) 0.86
  Viral load(log10 /ul) at day 0: median(IQR) 3.34(3.06, 4.45) 3.53(2.84, 5.07) 0.08
  Mortality(%) 17(43.59) 11(25.58) 0.11
  1. O oseltamivir monotherapy, O+P oseltamivir-peramivir combination therapy, IQR interquartile range, percentile 25 – percentile75